Merck EBIT 2010-2024 | MRK

Merck EBIT for the quarter ending September 30, 2024 was $3.984B, a 32.15% decline year-over-year.

  • Merck 2023 EBIT was 2.954B, a 83.84% decline from 2022.
  • Merck 2022 EBIT was 18.282B, a 38.51% increase from 2021.
  • Merck 2021 EBIT was 13.199B, a 137.91% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Merck EBIT 2010-2024 | MRK

  • Merck 2023 EBIT was 2.954B, a 83.84% decline from 2022.
  • Merck 2022 EBIT was 18.282B, a 38.51% increase from 2021.
  • Merck 2021 EBIT was 13.199B, a 137.91% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$710.1B
Novo Nordisk (NVO)$471.5B
Johnson & Johnson (JNJ)$373.6B
AbbVie (ABBV)$312.7B
Novartis AG (NVS)$213.1B
AstraZeneca (AZN)$203.5B
Pfizer (PFE)$145.4B
Sanofi (SNY)$122.5B
Innoviva (INVA)$1.2B